HoloSurge

Project Description

The HoloSurge project aims to refine the organ hologram technology, which was developed by Norwegian medtech company HoloCare.

This technology will be used to power informed surgical decision-making. It provides liver surgeons with interactive 3D holograms of organs and can be used by doctors to tailor operations to each person’s individual anatomy.

Using augmented reality headsets, such as the Microsoft HoloLens, surgeons are able to view a 3D hologram of a patient’s organ to plan operations more efficiently and accurately. The tool also allows them to move, rotate and expand the hologram, so that the organ can be viewed from above, below and behind. This enables the planning of operations more efficiently and accurately, which can potentially reduce complications.

The possibility of viewing the holograms remotely allows for the involvement of external specialists, which can ease decision-making during the planning process. The technology is initially being used for liver surgeries at five hospitals in Europe.

In the future, the HoloCare technology is expected to improve image-guided medical procedures, and allow for easier collaboration between experts, as well as the training of new experts.

Disclaimer: Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.

EU

Funded by
the European Union

HoloSurge is funded by the European Union (grant number XXXXXX)

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.